Follow-The-Filings

Security · featured owners

NERV Minerva Neurosciences Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $13M

NERV (Minerva Neurosciences Inc.) is held in 1 featured 13F book as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (0.06%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management 0.06%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management 2026 Q2 0.06% Hold 2,365,000 $13M History

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 21 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 3.03,5.03,5.07,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc
8-K 5.02,7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01 Filing Doc
424B3 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,3.02,5.03,7.01,9.01 Filing Doc
10-Q Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Aug 3, 2026 Filing Doc
4 Period Jun 3, 2026 · 7 forms Filing Doc
4 Period Apr 21, 2026 Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Dec 22, 2025 · 8 forms Filing Doc
4 Period Nov 14, 2025 Filing Doc

Updated 19 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.00 $0.00 —
Net income -$30.01M $1.44M -$293.42M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $42M $22.27M $83.1M
Total non-current assets * $14.9M $14.87M $14.87M
Total assets $56.9M $37.14M $97.97M
Total current liabilities $3.34M $2.84M $2.29M
Total non-current liabilities * $82.02M $60M $231.46M
Total equity -$28.46M -$25.69M -$140.75M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$14.78M -$19.55M -$13.51M
Cash from investing — $0.00 $0.00
Cash from financing $19.6M — $74.45M
Net change in cash $4.82M -$19.55M $60.94M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders